Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
237,4 CHF | -2,51% | -0,47% | -8,62% |
31/05 | ROCHE HOLDINGS AG : UBS vindt het aandeel niet inspirerend | ZD |
31/05 | Transcript : Roche Holding AG - Shareholder/Analyst Call |
Omzet 2024 * | 60,36 mld. 66,86 mld. 61,64 mld. | Omzet 2025 * | 63,82 mld. 70,69 mld. 65,16 mld. | Marktkapitalisatie | 186 mld. 207 mld. 190 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 13,27 mld. 14,7 mld. 13,55 mld. | Nettowinst (verlies) 2025 * | 14,76 mld. 16,35 mld. 15,07 mld. | EV/omzet 2024 * | 3,32 x |
Nettoschuld 2024 * | 13,79 mld. 15,27 mld. 14,08 mld. | Nettoschuld 2025 * | 7,91 mld. 8,76 mld. 8,08 mld. | EV/omzet 2025 * | 3,05 x |
K/w-verhouding 2024 * |
13,6
x | K/w-verhouding 2025 * |
12,3
x | Werknemers | - |
Dividendrendement 2024 * |
4,24% | Dividendrendement 2025 * |
4,36% | Vrij verhandelbaar | 88,91% |
Recentste transcriptie over Roche Holding AG
1 dag | -2,51% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 01-01-03 | |
Severin Schwan
CHM | Chairman | 57 | 01-01-08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01-04-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03-03-15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01-01-96 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
+6,17% | 164 mld. | |
-0,45% | 162 mld. | |
-.--% | 122 mld. |